<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985188</url>
  </required_header>
  <id_info>
    <org_study_id>2102-159-1199</org_study_id>
    <nct_id>NCT04985188</nct_id>
  </id_info>
  <brief_title>Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study</brief_title>
  <official_title>Quantitative Ultrasound Imaging Parameters for Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Multicenter Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Second People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samsung Medison</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the diagnostic performance of quantitative ultrasound parameters for assessing&#xD;
      hepatic steatosis in non-alcoholic fatty liver disease using histologic results as reference&#xD;
      standard&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 12, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic performance of quantitative ultrasound parameters for diagnosing hepatic steatosis (S1)</measure>
    <time_frame>1 month</time_frame>
    <description>Evaluation of area under the ROC curve (AUC) for the detection of fatty liver (S1)(reference standard: pathologic result)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance of quantitative ultrasound parameters for diagnosing hepatic steatosis (S2 and S3)</measure>
    <time_frame>1 month</time_frame>
    <description>Evaluation of area under the ROC curve (AUC) for the detection of fatty liver (S2 and S3)(reference standard: pathologic result)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance of quantitative ultrasound parameters for diagnosing nonalcoholic steatohepatitis (NASH)</measure>
    <time_frame>1 month</time_frame>
    <description>Evaluation of area under the ROC curve (AUC) for the detection of nonalcoholic steatohepatitis (reference standard: pathologic result)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Diagnoses Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantitative ultrasound (QUS) technique</intervention_name>
    <description>Measurement of quantitative ultrasound parameter using clinical US machine (RS85)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Clinically suspected or proven nonalcoholic fatty liver disease (NAFLD)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically suspected or proven nonalcoholic fatty liver disease (NAFLD)&#xD;
&#xD;
          -  Patients who are scheduled hepatic parenchymal biopsy for suspected liver disease or&#xD;
             hepatectomy for living donor liver donation&#xD;
&#xD;
          -  aged â‰¥ 18 years who are willing and able to complete all procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  excessive alcohol consumption within 2 years (40g/day for men, 20g/day for women)&#xD;
&#xD;
          -  clinical, laboratory, or histologic evidence of a liver disease other than NAFLD,&#xD;
             including viral hepatitis, autoimmune hepatitis, or genetic or acquired disorders&#xD;
&#xD;
          -  use of steatogenic or hepatotoxic medication&#xD;
&#xD;
          -  evidence of decompensated liver disease&#xD;
&#xD;
          -  history of liver surgery&#xD;
&#xD;
          -  any other condition believed by investigator to affect a patients' compliance, or&#xD;
             completion of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jeong Min Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeong Min Lee, MD</last_name>
    <phone>02-2072-3107</phone>
    <email>jmlshy2000@gmail.com</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Min Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

